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The initiation of reverse transcription of human immunodeficiency virus type 1 (HIV-1) exclusively utilizes tRNALys,3 as a
primer. Previous studies have shown that HIV-1 could use alternative tRNAs, such as tRNAIle or tRNAHis, to initiate reverse
transcription only if the primer binding site (PBS) was made complementary to the 39 terminal 18 nucleotides of the cognate
tRNA. However, upon in vitro culture, the viruses with a PBS complementary to the alternative tRNAs rapidly reverted to
generate a PBS complementary to tRNALys,3. To investigate the process of reversion, we have constructed defective proviral
genomes that contain a PBS complementary to tRNAIle or tRNAHis. The genomes contain the gene for xanthine-guanosine
phosphoribosyl transferase (gpt) in place of env. Cotransfection of these proviral genomes with a plasmid-encoding vesicular
stomatitis virus G protein (VSV-G) results in viruses that undergo a single round of HIV-1 infection; successful infections are
scored as cells resistant to the drug mycophenolic acid. Using this single-round infection system, we demonstrated that
HIV-1 with a PBS complementary to tRNAIle or tRNAHis is three- to fivefold less efficient in replication as measured by
production of drug-resistant cell colonies compared to the wild-type virus. These viruses predominantly used the cognate
tRNA as primer in their initial round of replication, although we did obtain a single cell colony in which the PBS was
complementary to tRNALys,3. Using an HIV-1 provirus with a PBS complementary to yeast tRNAPhe, we established a
single-round infection system in which the infectivity of this mutant HIV-1 relies on transfected yeast tRNAPhe. The results
of our studies suggest that the mechanism for selection of the tRNA primer for initiation of reverse transcription relies
primarily on the complementarity between the tRNA primer and the PBS. © 1999 Academic Press
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eINTRODUCTION
The initiation of retroviral reverse transcription occurs
t a region in the viral RNA genome designated as the
rimer binding site (PBS). The 18 nucleotides comprising
he PBS are complementary to the 39 terminal 18 nucle-
tides of the tRNA primer that is used for initiation of
everse transcription. The reverse transcriptase (RT) ex-
ends the 39 OH of the cellular tRNA molecule bound to
he PBS. Following completion of reverse transcription,
he DNA copy of the viral genome, termed the provirus, is
ntegrated into the host cell chromosome (Gilboa et al.,
979; Peters and Hu, 1980). During the plus-strand syn-
hesis step in reverse transcription, the RT copies the
RNA primer to generate a copy of the PBS (Taylor and
su, 1980). Thus the DNA sequence of the PBS from the
ntegrated provirus reflects the tRNA primer used for
nitiation of reverse transcription.
In general, retroviruses use different, but specific,
RNAs as primers for initiation of reverse transcription
Mak and Kleiman, 1997). For example, human immuno-
eficiency virus (HIV) exclusively uses tRNALys,3 as the
1 To whom reprint requests should be addressed. FAX: (205) 934-
t580. E-mail: casey morrow@micro. microbio.uab.edu.
042-6822/99 $30.00
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160rimer (Ratner et al., 1985, 1987). In contrast, HTLV-1
ses tRNALys1,2, rather than tRNALys,3, for initiation of
everse transcription; murine leukemia virus utilizes
RNAPro (Peters et al., 1977; Taylor, 1977) while avian
eukosis virus utilizes tRNATrp (Waters et al., 1975; Waters
nd Mullin, 1977). Previous studies from this laboratory
nd others have found that alteration of the PBS from
IV-1 to be complementary to tRNAs other than tRNALys,3
esulted in viruses using these alternative tRNAs for
nitiation of reverse transcription (Li et al., 1994; Das et
l., 1995; Wakefield et al., 1995; Kang et al., 1996). Thus
here appears to be a great deal of flexibility with respect
o different tRNAs that can be used for initiation of re-
erse transcription.
Although HIV-1 can use different tRNAs for initiation of
everse transcription when the PBS was altered so as to
e complementary to those different tRNAs, HIV-1 re-
erted to utilize the wild-type tRNA primer (tRNALys,3)
fter limited in vitro culture. The reason why these vi-
uses reverted back to utilize tRNALys,3 as opposed to
nother tRNA for initiation of reverse transcription is not
lear. Using an in vitro reconstituted reverse transcrip-
ion system, it has been shown that tRNALys,3 is the most
fficiently used primer for initiation of reverse transcrip-ion (Oude Essink et al., 1996). Previous studies from this
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161SELECTION OF tRNA PRIMER USED FOR REVERSE TRANSCRIPTIONaboratory have shown that nucleotide changes in U5
egion in combination with the PBS could affect the
election of tRNA used for initiation of reverse transcrip-
ion (Kang et al., 1996, 1997; Wakefield et al., 1996).
To further delineate the mechanism by which HIV-1
elects the tRNALys,3 for reverse transcription, we have
eveloped a system that allows examination of the sta-
us of the PBS following a single round of infection
Zhang et al., 1998b). For these studies, a defective pro-
irus was used in which the envelope gene has been
ubstituted with a gene encoding xanthine-guanosine
hosphoribosyl transferase (gpt) (Page et al., 1990).
omplementation of this defective genome with a suit-
ble glycoprotein (e.g., VSV-G) allows a single-round
nfection of this virus. Successful reverse transcription
vents are monitored by the production of cell clones
hat are resistant to mycophenolic acid. We have used
his system to compare the primer tRNA selection for
everse transcription of viruses with a PBS complemen-
ary to alternative tRNAs, tRNAHis or tRNAIle, with that of
he wild-type virus. The results of our study clearly show
hat viruses with a PBS complementary to these alterna-
ive tRNAs predominately used these tRNAs for the first
ound of infection. The capacity of the viruses with a PBS
omplementary to an alternative tRNA to induce drug
esistant colonies though was less than that of the wild-
ype virus. To exploit this result, we have also utilized an
IV-1 provirus with a PBS complementary to yeast
RNAPhe. Pseudotyped virus with a PBS complementary
o yeast tRNAPhe was not capable of generating drug-
esistant colonies unless yeast tRNAPhe was supplied in
rans. The results of our studies then are discussed with
espect to the mechanism by which tRNA is selected as
primer for reverse transcription.
RESULTS
onstruction of HIV-1 proviral genomes with a PBS
omplementary to tRNAHis or tRNAIle
In a previous study, we described the construction and
haracterization of complete HIV-1 proviral genomes in
hich the primer binding site (PBS) was changed to be
omplementary to tRNAHis or tRNAIle (Wakefield et al.,
995). Characterization of these viruses revealed the
ropensity to revert back to a PBS complementary to
RNALys,3 following limited in vitro culture. To ascertain
hether the cognate tRNA was actually used for initia-
ion of reverse transcription, we generated modified ge-
omes in which only the first nine nucleotides of PBS
ere complementary to tRNAHis or tRNAIle. Analysis of
he PBS regions from cultures obtained early after virus
rowth again revealed the presence of complete PBS
omplementary to the cognate tRNA (Wakefield et al.,
995). Based on these results, we concluded that the
ognate tRNA was used for the initiation of reverseranscription. A hallmark of all the analysis of the U5 yegions of the virus which used alternative RNA though
as the presence of numerous nucleotide changes
Wakefield et al., 1995; Kang et al., 1996). Since these
iruses had undergone multiple rounds of infection, it
as not clear whether the changes in U5 were abso-
utely essential for the virus to use the alternative tRNA to
nitiate reverse transcription. To address this issue, we
onstructed defective HIV-1 proviral genomes that con-
ained PBS complementary to tRNAHis or tRNAIle. The
nvelope gene of these genomes was replaced with the
ene encoding xanthine-guanine phosphoribosyl trans-
erase (gpt) (Fig. 1). Cotransfection of these defective
roviral genomes with a gene encoding VSV-G resulted
n the production of pseudoviruses that have the capacity
o undergo a single round of infection; the infected cells
ecome resistant to mycophenolic acid following suc-
essful integration of the provirus.
We first determined if the inclusion of the PBS com-
lementary to tRNAHis or tRNAIle would affect the pro-
uction of virus in the complementation assay. For these
tudies, plasmids were cotransfected into 293T cells,
nd the supernatants were analyzed for production of
irus particles by p24 antigen assay (Fig. 2). Our analysis
evealed that similar levels of p24 antigen were pro-
uced from cells cotransfected with the proviral ge-
omes containing either the wild-type PBS or PBS com-
lementary to tRNAHis or tRNAIle. Further experiments
ere performed by varying the ratio of plasmids encod-
ng the VSV-G envelope protein and the HIV-1 proviral
enome to optimize the production of virus particles as
easured by p24 (data not shown).
nalysis of the PBS in cell clones obtained after
nfection of HIV-1 with a PBS complementary
o tRNAHis or tRNAIle
To determine the effect of the PBS alternations, we
ext measured the numbers of drug-resistant cell colo-
ies obtained after infection with the wild-type virus or
iruses that contained a PBS complementary to tRNAHis
r tRNAIle. Different amounts of viruses were used to
stablish the linear range for the assay. Extrapolation
rom the linear region revealed that under our experi-
ental conditions, ;160 drug-resistant colonies per 100
icograms of p24 were obtained using the wild-type
irus. In contrast, we reproducibly obtained three- to
ivefold less drug-resistant cell colonies with an equal
mount of p24 from viruses that contained a PBS com-
lementary to tRNAHis or tRNAIle (Fig. 3).
The DNA sequence of the integrated PBS from indi-
idual drug-resistant cell colonies were next determined.
olonies were grown and the high molecular weight
NA was isolated. Using PCR primers specific for the
5-PBS region, we amplified this region followed by
ubcloning and DNA sequence analysis (Table 1). Anal-
sis of the colonies obtained from infection with wild-
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162 YU AND MORROWype virus revealed that all of the PBS were complemen-
ary to tRNALys,3. From the cell clones derived from in-
ection of virus with a PBS complementary to tRNAIle, the
ajority of the PBS recovered were complementary to
RNAIle, with the exception of a single PBS complemen-
ary to tRNALys,3. Only PBS complementary to tRNAHis
ere recovered from colonies obtained following infec-
ion with the virus containing a PBS complementary to
FIG. 1. Defective HIV-1 proviral genomes (A) The defective HIV-1 pro
ibosyl transferase (gpt) under control of the SV40 early promoter has
lasmid was cotransfected with the plasmid encoding VSV-G protein. In
cid. (B) Substitution of the PBS to be complementary to tRNAIle, tRNA
BS were designated as psHIV-Ile, psHIV-His, or psHIV-Phe, respectivel
FIG. 2. Release of viruses following transfection of defective provi-
uses. 293T cells were cotransfected with the designated proviruses
nd the VSV-G expression plasmid. At 48 h posttransfection, the su-
ernatants were analyzed for released p24 antigen by ELISA. The
ean values of p24 obtained from three independent transfections with
tandard deviations is depicted. The designations psHIV-wt, psHIV-Ile,
nd psHIV-His correspond to pseudoviruses with PBS complementaryno tRNALys,3, tRNAIle, or tRNAHis, respectively.RNAHis. Taken together, the results of these studies
learly demonstrate that in the initial round of infection
irus with a PBS complementary to alternative tRNA
tilizes that tRNA for initiation of reverse transcription.
he use of tRNALys,3 as primer by virus with a PBS
omplementary to tRNAIle in first round of replication is
onsistent with our previous observation that following in
itro culture, virus containing a PBS complementary to
RNAIle reverted back to wild type faster than virus with a
BS complementary to tRNAHis (Wakefield et al., 1995).
omplementation of an HIV-1 provirus with a PBS
omplementary to yeast tRNAPhe
In previous studies, we had identified and character-
zed an HIV-1 provirus in which the PBS was genetically
ngineered to be complementary to the 39 terminal 18
ucleotides of yeast tRNAPhe. This virus was not infec-
ious in our tissue culture system unless we changed the
irst six nucleotides of the PBS to be complementary to
RNALys,3, then the virus used tRNALys,3 to initiate reverse
ranscription (Wakefield et al., 1994; Wakefield and Mor-
ow, 1996). To further characterize this virus, we engi-
eered the PBS complementary to yeast tRNAPhe into the
efective proviral genome. Transfection of this defective
roviral genome with the plasmid encoding the VSV-G
enerated similar levels of p24 antigen in the superna-
ant as the cotransfection of the proviral genome con-
aining the wild-type PBS with the plasmid encoding
SV-G (data not shown). Upon infection of cells with the
seudotyped virus containing the PBS complementary to
RNAPhe, we were unable to recover any substantial
nome is depicted. The gene encoding xanthine-guanosine phospho-
substituted for the env gene. To generate pseduotyped viruses, this
of cells with the pseudotyped virus confers resistance to mycophenolic
yeast tRNAPhe. The defective proviral genomes containing the mutant
efective proviral genome with wild-type PBS is referred to as psHIV-wt.viral ge
been
fection
His, orumbers of drug-resistant cell colonies. Thus consistent
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163SELECTION OF tRNA PRIMER USED FOR REVERSE TRANSCRIPTIONith our previous studies, the virus with a PBS comple-
entary to yeast tRNAPhe had greatly reduced infectivity.
ince the results from the previous section had shown
hat in the first-round infection, viruses predominantly
tilized the tRNA complementary to the PBS, we wanted
o determine whether the infectivity of virus with the PBS
omplementary to yeast tRNAPhe could be restored by
roviding yeast tRNAPhe in trans. For these studies, we
tilized three different sources of yeast tRNAPhe: a com-
ercially available preparation of isolated yeast tRNAPhe,
second preparation of isolated yeast total tRNAs, and a
reparation of yeast tRNAPhe obtained from in vitro tran-
cription using a cDNA template. Previous studies have
ound the yeast tRNAPhe generated from in vitro tran-
cription using this cDNA is similar to the wild type with
he exception of the post transcriptional modifications of
pecific bases (Sampson and Uhhenbeck, 1988). Using
ptimized ratio of the plasmid encoding the HIV-1 provi-
us with the PBS complementary to tRNAPhe and the
lasmid encoding VSV-G, we added increasing amounts
f the various tRNAs, up to 4 mg, into the cotransfection
ixture. The resultant pseudoviruses were normalized
or p24 and used to infect cells followed by mycophenolic
cid selection. As expected, without the addition of yeast
RNA, few colonies were recovered (,1 colony per nano-
ram of p24). However, with the addition of the yeast
RNA, we found a dose-dependent increase in the num-
er of drug-resistant colonies (Fig. 4). The greatest num-
er of colonies was obtained using tRNAPhe isolated
rom yeast. We found a similar number of colonies using
FIG. 3. Comparison of infectivity of HIV-1 viruses with a PBS com-
lementary to tRNAIle (psHIV-Ile) or tRNAHis (psHIV-His) with the wild-
ype virus (psHIV-wt). The designated pseudoviruses generated by
otransfection of proviruses with VSV-G plasmid were measured by
24 ELISA. Serial dilutions of each virus (p24) were used to infect cells
ollowed by selection in mycophenolic acid. The average numbers of
rug-resistant colonies derived from independent virus infections is
epicted.east tRNAPhe from in vitro transcription of the cDNA sncoding yeast tRNAPhe (300-fold over background). The
umber of colonies obtained using in vitro transcribed
east tRNAPhe was also greater than that obtained using
similar amount of total tRNAs (where tRNAPhe is in
ower amounts) isolated from yeast. Taken together, the
esults of these studies demonstrate that cotransfecting
he cognate tRNA with the defective HIV-1 proviral ge-
ome resulted in the production of a virus, which can
ndergo a productive infection as measured by the ca-
acity to generate drug-resistant cell clones.
To further investigate the specificity of the complemen-
ation, we performed cotransfection experiments with
RNAs isolated from rabbit or calf liver using two different
RNAs concentrations (2 and 0.2 mg) within the linear
ange of the assay in the cotransfection (Fig. 5). The
solated or in vitro transcribed yeast tRNAPhe again gave
he greatest numbers of colonies, although the absolute
umber of colonies were reduced compared to that pre-
ented in Fig. 4. These differences might be due to
ariations between independent transfections. More im-
ortantly, only background numbers of colonies (,1 col-
ny per nanogram p24) were obtained following cotrans-
ection with different concentrations of rabbit or calf
RNAs, confirming the specificity of the complementation
y yeast tRNAPhe. To further characterize the reverse
ranscription reaction with the yeast tRNAPhe as primer,
e analyzed the PBS of the integrated proviruses ob-
ained from individual cell clones (Table 2). All of the cell
lones analyzed contained a PBS complementary to
east tRNAPhe. Most interestingly, among the cell clones
erived from infection of virus complemented by in vitro
ranscribed yeast tRNAPhe, we found a single clone of 19
lones contained a sequence complementary to the full-
ength (76-nucleotide) tRNAPhe; the majority though (18
lones) contained the PBS complementary to the 39 ter-
TABLE 1
HIV-1 with Alternative PBS Predominantly Used the Cognate tRNA
as Primer in Initial Round of Replication
PBS of input
provirus
No. of cell clones
used for
sequencinga
Sequence of integrated
provirus PBS
BSLys,3 (wt)b 12 12/12: PBSLys,3c
BSIle 14 13/14: PBSIle
1/14: PBSLys,3
BSHis 12 12/12: PBSHis
a Envelope-deficient proviruses with PBS complementary to tRNALys,3
wt), tRNAIle, or tRNAHis were cotransfected with plasmid encoding
SV-G. The resultant pseudoviruses were used to infect cells to induce
rug-resistant colonies. Individual drug-resistant colonies were cloned
nd the PBS sequence of integrated proviruses determined.
b Designated PBSLys,3 PBSIle, and PBSHis represent PBS complemen-
ary to tRNALys,3, tRNAIle, or tRNAHis, respectively.
c Number of independent PCR clones and number of designated
equences recovered.
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164 YU AND MORROWinal 18 nucleotides of yeast tRNAPhe. Taken together,
he results of these studies demonstrate that the unmod-
fied tRNA can function as a primer for initiation of re-
erse transcription when supplied in trans.
DISCUSSION
In this report, we have investigated the mechanism of
election of the tRNA used for initiation of HIV-1 reverse
ranscription. Using a defective provirus that can only
ndergo a single round of replication, we demonstrated
hat HIV-1 with a PBS complementary to tRNAHis or
RNAIle predominantly utilized these tRNAs for the first
ound of replication. The efficiency of the initiation of
everse transcription, as determined by production of
rug resistant cell colonies, was three- to fivefold lower
or the viruses that utilized tRNAHis or tRNAIle as primer
ompared to the wild-type virus. A complementation sys-
em was developed to study the selection of the tRNA
sed for initiation of reverse transcription. A defective
rovirus with a PBS complementary to yeast tRNAPhe
as constructed that was only infectious upon cotrans-
ection of native (modified) yeast tRNAPhe or tRNAPhe
btained from in vitro transcription of a cDNA template.
The details for the selection of the tRNA primer used
or initiation of reverse transcription are currently un-
nown. Previous studies from this laboratory, as well as
thers, have established that alteration of the PBS to be
omplementary to tRNAs other than tRNALys,3 resulted in
iruses able to utilize these alternative tRNAs for the
nitiation of reverse transcription (Li et al., 1994; Das et
l., 1995; Wakefield et al., 1995; Kang et al., 1996). The
FIG. 4. Complementation of psHIV-Phe virus by cotransfected yeast tR
rom the infection of viruses generated by cotransfecting psHIV-Phe pro
RNAPhe, in vitro transcribed yeast tRNAPhe, or yeast total tRNAs. The n
olony per nanogram of p24.iruses though rapidly reverted to utilize tRNALys,3 for wnitiation of reverse transcription after limited in vitro
ulture. Due to the complexity of the in vitro culture
ystem, it was not possible to determine whether the
iruses with a PBS complementary to the alternative
RNAs predominantly used the alternative tRNAs for the
irst round of replication. That is, it was possible that
iruses with the PBS complementary to different tRNAs
ould not discriminate during the first round of replica-
ion between the cognate tRNA and tRNALys,3. If the latter
as the case, it might provide support for a role of viral
roteins, other than the complementarity between tRNA
nd PBS, in selection of the tRNA used to initiate reverse
ranscription. The results of the current study clearly
stablish that complementarity between the PBS and an
lternative tRNA is a major determinant for the selection
nd use of this tRNA in initiation of reverse transcription.
ur data indicate that the vast majority of the initial
everse transcription events utilize the tRNA primer com-
lementary to PBS. Upon analysis of clones derived from
nfection of the virus with PBS complementary to tRNAIle,
e did find a single clone with the PBS complementary
o tRNALys,3. Even during the first round of infection then,
everse transcription was initiated with tRNALys,3 on a
BS complementary to tRNAIle. This result correlates
ith our previous finding that reversion of virus with a
BS complementary to tRNAIle occurred very rapidly in
he in vitro culture (Wakefield et al., 1995). Why tRNALys,3
an be more effectively positioned onto a PBS com-
lementary to tRNAIle but not tRNAHis is not clear. It
hould be noted that the PBS complementary to tRNAIle
r tRNAHis have 9- and 7-bp mismatches, respectively,
. Values represent average numbers of drug-resistant colonies derived
nd VSV-G expression plasmid with indicated amounts of isolated yeast
of colonies obtained without cotransfection of yeast tRNAPhe was ,1NAPhe
virus a
umberith the 39 terminus of tRNALys.3. Thus our results that
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165SELECTION OF tRNA PRIMER USED FOR REVERSE TRANSCRIPTIONRNALys,3 can be positioned onto the PBS complemen-
ary to tRNAIle are not fully explained by greater base pair
omplementarity in the PBS. Most probably, the entire
5-PBS RNA structure also contributes, although not as
trongly as complementarity with the PBS, to the utiliza-
ion of a specific tRNA for initiation of reverse transcrip-
ion. Further experiments, using this single-round sys-
em, will be required to elucidate the features of the
5-PBS involved in selection of the tRNA primer.
The results from our current study do provide a clue as
FIG. 5. Specificity of tRNA complementation of psHIV-Phe replication.
wo micrograms (A) or 0.2 mg (B) of indicated tRNAs isolated from the
esignated sources were added in cotransfections to complement
sHIV-Phe virus. Bar graph illustrates average numbers of drug-resis-
ant colonies derived from the infection of psHIV-Phe pseudoviruses
ith various tRNAs. The asterisk corresponds to less than 1 colony/ng
24.o why viruses with a PBS complementary to an alterna- qive tRNA are unstable and revert back to utilize tRNALys,3
or initiation of reverse transcription. Using these single
ound analysis, we found that viruses with a PBS com-
lementary to tRNAHis or tRNAIle were generally three- to
ivefold less efficient in replication as measured by gen-
ration of drug-resistant colonies. While this might not
eem significant, this difference, when amplified over
ultiple rounds of infection, would probably result in a
onsiderable difference in the replication of the mutant
irus compared to the wild type. Thus viruses that can
tilize tRNALys,3 for initiation of reverse transcription
ight have a significant replication advantage following
ultiple rounds of re-infection and would, most probably,
ominate over the mutant viruses in a continuous culture
ystem. In previous studies, we have found viruses that
an stably utilize alternative tRNAs for initiation of re-
erse transcription (Wakefield et al., 1996; Kang et al.,
997; Zhang et al., 1998a). Additional mutations within the
5 of these viruses were found following extended in
itro culture. At the time, we speculated that these addi-
ional mutations along with the PBS complementary to
he alternative tRNA were required for the virus to more
fficiently utilize this tRNA for reverse transcription. In
upport of this hypothesis, preliminary experiments
how that defective provirus with a U5-PBS optimized for
se of tRNAHis generated a greater number of drug-
esistant colonies, than the provirus with only a PBS
omplementary to tRNAHis (Yu and Morrow, unpub-
ished).
The fact that alteration of the PBS to be complemen-
ary to alternative tRNAs resulted in the use of these
RNAs as reverse transcription primer in the single-round
nfection assay system prompted us to determine
hether we could supply in trans the tRNA to be used for
nitiation of reverse transcription. For these studies, we
ade use of a previously described HIV-1 provirus in
TABLE 2
HIV-1 with PBS Complementary to Yeast tRNAPhe Used Yeast
tRNAPhe Supplied in Trans to Initiate Reverse Transcription
tRNAs cotransfected
with psHIV-Phe
No. of cell
clones used
for sequencinga
Sequence of
integrated provirus PBS
east total tRNAs 4 4/4: PBSPhe
east tRNAPhe 4 4/4: PBSPhe
east tRNAPhe
(in vitro transcribed)
19 18/19: PBSPhe; 1/19:
sequence complementary
to full-length tRNAPhe
a Plasmid containing psHIV-Phe provirus and plasmid encoding
SV-G were co-transfected with indicated tRNA species to generate
seudoviruses. These viruses were used to infect cells which were
hen selected with mycophenolic acid. Individual cell colonies were
solated and the PBS was amplified by PCR and the DNA sequence
ere determined. Numbers refer to independent cell clones se-
uenced and number obtained with designated DNA sequence.
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166 YU AND MORROWhich the PBS was mutated so as to be complementary
o yeast tRNAPhe; under our in vitro culture conditions
his virus was noninfectious (Wakefield et al., 1994). We
ntroduced the PBS complementary to yeast tRNAPhe into
he defective proviral genome. The pseudotyped virus
hat contained a PBS complementary to yeast tRNAPhe
id not produce significant quantities of drug-resistant
ell colonies. To restore virus infectivity, we cotrans-
ected the provirus with yeast tRNAPhe; both native yeast
RNAPhe (i.e., containing modified bases) as well as in
itro transcribed tRNAPhe could complement the defec-
ive proviral genome. This is the first demonstration for
he conditional replication of HIV-1 virus by providing the
RNA molecule in trans. The results of our studies are
onsistent with previous studies from Lund et al. (1997),
ho demonstrated that murine leukemia virus could be
estored upon transfection of packaging cells with plas-
ids encoding a genetically modified tRNA. Our study
iffers from Lund et al. (1997) though, because we used
n vitro transcribed tRNA for complementation. The re-
ults of our study lend support to the idea that the tRNA
olecule interacts with the viral RNA genome within the
ell (presumably in the cytoplasm) prior to release of
irus as opposed to the viral proteins selecting the tRNA
sed for initiation of reverse transcription. Interaction
etween a tRNA molecule and the viral RNA genome
rior to release of the virus would also explain the ca-
acity of HIV-1 to utilize different tRNA molecules for the
nitiation of reverse transcription when the PBS is made
o be complementary to these different tRNAs.
The establishment of a system whereby we can ma-
ipulate both the viral RNA genome as well as the tRNA
rimer by mutagenesis will also allow us to further define
he regions of the tRNA molecules which are important
or the interaction with the viral RNA genome. Although
he modified bases found in tRNAs are not absolutely
equired for the tRNA to function as a primer for initiation
f reverse transcription, the native yeast tRNAPhe mole-
ules did complement more effectively than the in vitro
ranscribed molecules, suggesting that the modified
ases could facilitate the reverse transcription process.
he modified bases could function by inhibiting the re-
erse transcriptase from copying .18 nucleotides from
he 39 terminal region of tRNA primer during plus-strand
ynthesis (Arts and Le Grice, 1998). This idea is sup-
orted by our finding that one of the cell clones, which
as derived from infection of the virus complemented by
n vitro transcribed tRNAPhe, contained the complete 76-
ucleotide sequence of yeast tRNAPhe in the PBS region
f integrated virus. Presumably, this sequence was gen-
rated during the plus-strand synthesis when the reverse
ranscriptase utilized the tRNAPhe as template for the
eneration of a plus stand PBS. Ultimately the use of the
n vitro transcribed tRNAPhe in this system will help us to
erive a detailed picture of which regions of the tRNA
olecule are important for interaction with the viral RNA senome to function as a primer for initiation of reverse
ranscription. This information could be used in the future
o design therapeutics targeted to disrupt the tRNA-PBS
nteraction, which is essential for the initiation of HIV
everse transcription.
MATERIALS AND METHODS
aterials
All chemicals were purchased from Sigma Chemical
o. unless otherwise specified. Restriction endonucle-
se were obtained from New England Biolabs. The Taq
olymerase and reagents for PCR, the tissue culture
edium and reagents, the synthetic oligonucleotides
sed for PCR and DNA sequencing, and lipofectin were
urchased from GIBCO BRL. The calcium-phosphate
ransfection kit was obtained from Qiagen. The enzyme-
inked immunosorbent assays (ELISAs) for p24 antigen
ere obtained from Coulter Laboratories.
issue culture and cell lines
293T cells and HeLa H1 cells were maintained in
ulbecco’s modified Eagle’s medium (DMEM) plus 10%
etal calf serum (FCS) and 1% antibiotics in 37°C incu-
ator supplied with 5% CO2.
onstruction of HIV-1 proviruses
pHXB2gpt, a plasmid encoding the full-length HIV-1
rovirus, with modified PBS, were used for plasmid con-
truction: pHXB2(Ile) contains a PBS region complemen-
ary to the 39-terminal 18 nucleotide sequence of tRNAIle;
HXB2(His) contains a PBS region complementary to the
9-terminal 18 nucleotide sequence of tRNAHis (Wakefield
t al., 1995); pHXB2(Phe) contains a PBS region comple-
entary to the 39-terminal 18 nucleotide sequence of
east tRNAPhe (Wakefield et al., 1994). pHXB2gpt with a
ild-type PBS is referred as pHXB2(wt).
Plasmid HIV-gpt containing the mutant HIV-1 proviral
enome was kindly provided by Dr. Dan Littman (Page et
l., 1990). HIV-gpt has a 1.2-kb deletion in env gene. A
.1-kb fragment containing the simian virus 40 (SV40)
romoter and the xanthine-guanosine phosphoribosyl
ransferase (gpt) gene was inserted at the env site (Page
t al., 1990). This env deletion and gpt insertion were
ransferred into pHXB2(wt), pHXB2(Ile), pHXB2(His), and
HXB2(Phe) by substituting the SalI-XbaI fragment of
hese pHXB2 plasmids with the SalI-XbaI fragment from
IV-gpt. The resulting HIV-1 proviral clones are referred
o as psHIV-wt, psHIV-Ile, psHIV-His, and psHIV-Phe,
espectively (Fig. 1).
Plasmid pLGRNL used to express vesicular stomatitis
irus G glycoprotein (VSV-G) has been previously de-
cribed (Burns et al., 1993).
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167SELECTION OF tRNA PRIMER USED FOR REVERSE TRANSCRIPTIONn vitro transcription
Plasmid p67YF0, which contains the yeast tRNAPhe
ene, was kindly provided by Dr. Uhlenbeck (Sampson
nd Uhhenbeck, 1988). p67YF0 contains a T7 promoter
irectly adjacent to the yeast tRNAPhe gene and a BstNI
estriction site at the 39 end of the gene. Runoff transcrip-
ion of the BstNI-digested p67YF0 would give a 76-nu-
leotide RNA identical to an unmodified yeast tRNAPhe.
he transcription reactions were carried out using a
ommercial in vitro transcription kit (GIBCO), following
he instruction of manufacturer.
ransfection and selection of drug-resistant cell lines
The human embryonal kidney cell line 293T was used
or all transfections. Calcium-phosphate (Qiagen) was
sed to transfect plasmid DNA to produce virus as in-
tructed by the manufacturer. When cotransfecting both
lasmid DNA and tRNA, lipofectin (GIBCO) was used
ollowing manufacturer’s instruction. At 48 h posttrans-
ection, the supernatants were collected and filtered
hrough a 0.45-mm pore-size filter (Nalgene). Virus pro-
uction was monitored by measuring the p24 antigen
evels using a commercial ELISA kit (Coulter Laborato-
ies).
Different dilutions of viruses produced by cotransfections
ere used to infect HeLa H1 cells. At 2 h after infection, the
ells were washed once and then fresh DMEM plus 10%
CS and 1% antibiotics was added. At 24 h after infection,
he medium was replaced with the selection medium
DMEM containing 10% FCS, 1% antibiotics, 20 mM HEPES
pH 7.5), 250 mg of xanthine/ml, and 50 mg mycophenolic
cid/ml]. This medium was changed every 2–3 days until
olonies of drug-resistant cells were formed (10–14 days).
o determine the colony number, colonies were fixed by 5%
richloroacetic acid (TCA) solution and stained with 2%
oomassie blue. For sequence analysis, individual colo-
ies were isolated using cloning cylinder (Specialty Media)
ollowing the instructions of manufacturer. Each isolated
olony was expanded in selection medium and used to
solate chromosomal DNA by using a Wizard DNA isolation
it (Promega). The U5-PBS region of integrated HIV-1 pro-
irus in the isolated chromosomal DNA was amplified by
CR with following primers: primer 1 (59-TAGACCAGATCT-
AGCCTGGGAGCTC-39; nt 13–48), and primer 2 (59-CTC-
TTCTAGCCTCCGCTAGTC-39, complementary to nt 331–
10). The PCR-amplified fragments were cloned into pGEM-
-Easy vector (Promega). The resultant plasmid DNA were
mplified and prepared for sequence analysis.
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